• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Canon plunges on $3B EU fine threat over Toshiba Medical deal

Canon plunges on $3B EU fine threat over Toshiba Medical deal

July 7, 2017 By Brad Perriello

Canon logo(Reuters) — Canon (NYSE:CAJ) shares fell to their lowest levels in more than two months today after European regulators said they may fine it up to 10% of annual revenue for jumping the gun in its acquisition of Toshiba’s (TYO:6502) medical unit.

The European Union Commission said it had reached a preliminary view that Canon breached rules by using a so-called “warehousing” two-step transaction structure involving an interim buyer to buy the company prior to obtaining relevant approvals.

Ten percent of Canon’s annual revenue would be roughly equivalent to $2.9 billion.

The $6 billion deal, completed late last year, raised eyebrows at the time due to the unorthodox method which allowed Toshiba, which was struggling for cash after an accounting scandal, to book proceeds in time for the financial year-end in March.

At the time, rival bidder Fujifilm Holdings (TSE:4901) criticized the deal as a “mockery of the law.”

Canon said in statement that it would respond appropriately, but declined further comment before regulators make their final decision.

Canon shares closed down -3.8% at ¥3,652.00 ($32.10) apiece today in Tokyo, their lowest level since May 1. The stock was the fifth-most traded stock by turnover.

EU regulators also accused GE Healthcare (NYSE:GE) and German drugmaker Merck (NYSE:MRK) yesterday of providing misleading information during separate merger deals.

Facebook (NSDQ:FB) was hit with a €110 million ($125 million) fine in May for providing misleading information during the EU review of its messaging service WhatsApp purchase in 2014. Last month, EU antitrust regulators hit Alphabet (NSDQ:GOOGL) unit Google with a record 2.4-billion-euro fine for favouring its own shopping service.

($1 = €0.8766; $1 = ¥113.757)

Filed Under: Mergers & Acquisitions, Wall Street Beat Tagged With: Canon, European Commission, Toshiba

More recent news

  • Former Intuitive sales leader joins surgical robot maker Virtual Incision as CEO
  • Smith+Nephew to open first orthopedic ambulatory surgery center in the UK
  • Medtronic partners with IRCAD on Hugo, Affera surgical training
  • 23andMe co-founder wins bid to take back control of company
  • Neurent Medical opens new manufacturing facility in Ireland

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy